These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 5999068)
41. Management of retinitis pigmentosa--summary. Bird AC Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():494-5. PubMed ID: 6589868 [No Abstract] [Full Text] [Related]
42. [Blood-retinal barrier and visual field in retinitis pigmentosa]. Gierek-Lapińska A; Szymański A; Koziak M; Gierek-Kalicka S; Dudziński A Klin Oczna; 1993 Jan; 95(1):29-31. PubMed ID: 8479138 [TBL] [Abstract][Full Text] [Related]
43. [The characteristics of retinitis pigmentosa with retinal vascular occlusion]. Wang GL; Lu N; Zhang F; Peng XY; Li Y; Wang MY Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):414-8. PubMed ID: 15938805 [TBL] [Abstract][Full Text] [Related]
44. Serum ceruloplasmin and immunoglobulins in retinitis pigmentosa patients. Jain IS; Singh KP; Dhir SP Ann Ophthalmol; 1981 Jun; 13(6):733-4. PubMed ID: 7258970 [TBL] [Abstract][Full Text] [Related]
45. Early receptor potential in retinitis pigmentosa. Khosla PK; Madhok P; Gahlot DK Indian J Ophthalmol; 1983 May; 31(3):228-32. PubMed ID: 6676225 [No Abstract] [Full Text] [Related]
49. Pigmentary retinopathy, hearing loss, mental retardation, and dysmorphism in sibs: a new syndrome? Hersh JH; Podruch PE; Weisskopf B Birth Defects Orig Artic Ser; 1982; 18(3B):175-82. PubMed ID: 7139098 [No Abstract] [Full Text] [Related]
50. [Study of the global and local adaptation and of the summation coefficients in pigmentary retinopathies]. Sucs S Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1966 Oct; 171(1):42-50. PubMed ID: 5296879 [No Abstract] [Full Text] [Related]
51. An assessment of antimalarials in the treatment of the connective tissue diseases. Kersley GD Practitioner; 1966 Jul; 197(177):57-9. PubMed ID: 5947087 [No Abstract] [Full Text] [Related]